pqq cofactor has been researched along with Ventricular Fibrillation in 2 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoprolol and/or PQQ were given at the onset of reperfusion to mimic clinical treatment." | 1.33 | Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. ( Cecchini, G; Karliner, JS; Li, L; Simonis, U; Teerlink, JR; Zhou, HZ; Zhu, BQ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, BQ | 2 |
| Zhou, HZ | 2 |
| Teerlink, JR | 2 |
| Karliner, JS | 2 |
| Simonis, U | 1 |
| Cecchini, G | 1 |
| Li, L | 1 |
2 other studies available for pqq cofactor and Ventricular Fibrillation
| Article | Year |
|---|---|
Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.
Topics: Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests | 2004 |
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Body Weight; Cardiotonic Agents; Creatine Kinase | 2006 |